RESUMO
Erythroderma is characterized by diffuse erythema and scale covering over 90% body surface area that can affect individuals with inflammatory dermatoses such as psoriasis. Complications of erythrodermic psoriasis include infection and cardiovascular compromise. Here we present a case of a 68 year-old man who was hospitalized for erythrodermic psoriasis refractory to multiple immunosuppressive and immunomodulatory therapies, ultimately developing sepsis due to bacteremia and fungemia complicated by infective endocarditis and a mycotic aneurysm. Although the widespread loss of epidermal function in erythroderma increases the risk of infection by opportunistic pathogens, water loss, and electrolyte imbalances, there are very few reported cases of psoriatic erythroderma complicated by fungemia and mycotic aneurysm. Given the high mortality associated with widespread epidermal dysfunction, there is a great need for evidence-based treatment guidelines for psoriatic erythroderma. J Drugs Dermatol. 2024;23(8): doi:10.36849/JDD.7751.
Assuntos
Aneurisma Infectado , Dermatite Esfoliativa , Psoríase , Choque Séptico , Humanos , Masculino , Psoríase/complicações , Psoríase/tratamento farmacológico , Psoríase/diagnóstico , Idoso , Dermatite Esfoliativa/diagnóstico , Dermatite Esfoliativa/etiologia , Dermatite Esfoliativa/terapia , Dermatite Esfoliativa/tratamento farmacológico , Choque Séptico/diagnóstico , Choque Séptico/microbiologia , Choque Séptico/terapia , Choque Séptico/etiologia , Aneurisma Infectado/diagnóstico , Aneurisma Infectado/terapia , Aneurisma Infectado/microbiologia , Evolução Fatal , Fungemia/diagnóstico , Fungemia/tratamento farmacológico , Fungemia/microbiologia , Fungemia/complicações , Guias de Prática Clínica como Assunto , Bacteriemia/diagnóstico , Bacteriemia/tratamento farmacológico , Bacteriemia/complicações , Bacteriemia/microbiologiaAssuntos
Dermatite Esfoliativa , Interleucina-17 , Psoríase , Humanos , Psoríase/tratamento farmacológico , Psoríase/imunologia , Interleucina-17/antagonistas & inibidores , Interleucina-17/imunologia , Estudos Retrospectivos , Masculino , Feminino , Resultado do Tratamento , Pessoa de Meia-Idade , Dermatite Esfoliativa/tratamento farmacológico , Adulto , Anticorpos Monoclonais Humanizados/efeitos adversos , Anticorpos Monoclonais Humanizados/uso terapêutico , Fármacos Dermatológicos/uso terapêutico , Fármacos Dermatológicos/efeitos adversos , Idoso , Índice de Gravidade de Doença , Adalimumab/uso terapêutico , Adalimumab/efeitos adversosRESUMO
Erythroderma is a dermatological emergency presenting with generalized erythema and scaling involving <90% of the body surface.1 There are various causes of erythroderma, such as psoriasis, atopic dermatitis, phytophotodermatitis, pityriasis rubra pilaris, pemphigus foliaceus, cutaneous T-cell lymphoma, and drug eruptions.2 However, erythroderma induced by dermatophytosis is encountered rarely. We, here, describe a case of erythroderma developed secondary to extensive dermatophytosis.
Assuntos
Dermatite Esfoliativa , Humanos , Antifúngicos/uso terapêutico , Dermatite Esfoliativa/etiologia , Dermatite Esfoliativa/diagnóstico , Dermatite Esfoliativa/tratamento farmacológico , Tinha/diagnóstico , Tinha/tratamento farmacológicoAssuntos
Humanos , Masculino , Recém-Nascido , Pele/lesões , Exantema , Dermatite Esfoliativa/tratamento farmacológico , Staphylococcus aureus , Floxacilina/administração & dosagem , Síndrome da Pele Escaldada Estafilocócica/tratamento farmacológico , Resultado do Tratamento , Pacientes Internados , Síndrome da Pele Escaldada Estafilocócica/complicações , Exame Físico , Doenças do Recém-NascidoRESUMO
The diagnosis of scabies can be difficult when the infection presents as erythroderma. Crusted scabies is a severe form of scabies caused by cutaneous ectoparasitic infection by the mite Sarcoptes scabiei var hominis. Crusted scabies most commonly occurs in patients with underlying immunosuppression from acquired infection or subsequent to solid organ or bone marrow transplantation. We present a rare case of a patient with granulomatosis with polyangiitis (GPA) who developed azathioprine-induced myelosuppression and subsequent erythrodermic crusted scabies. It is critical to maintain a broad differential when patients present with erythroderma, especially in the setting of medication-induced immunosuppression for the treatment of autoimmune disease.
Assuntos
Dermatite Esfoliativa , Granulomatose com Poliangiite , Escabiose , Animais , Humanos , Escabiose/complicações , Escabiose/diagnóstico , Escabiose/tratamento farmacológico , Dermatite Esfoliativa/diagnóstico , Dermatite Esfoliativa/tratamento farmacológico , Dermatite Esfoliativa/etiologia , Sarcoptes scabiei , Terapia de Imunossupressão , Celulite (Flegmão) , Doença IatrogênicaAssuntos
Dermatite Esfoliativa , Micose Fungoide , Neoplasias Cutâneas , Humanos , Brentuximab Vedotin , Dermatite Esfoliativa/tratamento farmacológico , Dermatite Esfoliativa/etiologia , Micose Fungoide/complicações , Micose Fungoide/tratamento farmacológico , Neoplasias Cutâneas/complicações , Neoplasias Cutâneas/tratamento farmacológicoRESUMO
Tuberculosis is a serious contagious disease mainly affecting the lungs and is common in the developing countries. The essential component of all antitubercular regimens include Isoniazid, pyrazinamide as first-line drugs. A serious cutaneous adverse drug reaction namely exfoliative dermatitis (erythroderma) is associated with isoniazid use though uncommon but is common among pyrazinamide users. Here we report 3 cases of tuberculosis patients on antitubercular therapy (ATT) for 8 weeks, came to hospital OP (outpatient) with severe generalized redness and scaling with itching distributed all over the body and trunk. Immediately ATT was discontinued and all the three patients were administered antihistaminic and corticosteroid. The patients recovered within 3 weeks. To confirm ATT induced erythroderma and narrow down the offending agents, sequential rechallenge with ATT was done and again these patients had similar lesions erupt all over the body only with isoniazid and pyrazinamide. Antihistamine, steroids were started and the symptoms resolved and completely recovered within 3 weeks. Prompt withdrawal of the culprit drug along with appropriate medications and supportive measures is necessary for good prognosis. Physicians must be judicious while prescribing ATT especially, isoniazid and pyrazinamide as these can precipitate fatal cutaneous adverse reactions. Strict vigilance may help in early detection of this type ADR and timely management.
Assuntos
Dermatite Esfoliativa , Tuberculose , Humanos , Isoniazida/efeitos adversos , Pirazinamida/efeitos adversos , Dermatite Esfoliativa/induzido quimicamente , Dermatite Esfoliativa/tratamento farmacológico , Antituberculosos/efeitos adversos , Tuberculose/tratamento farmacológicoRESUMO
CARD14-associated papulosquamous eruption (CAPE) was proposed in 2018 to describe the clinical features of psoriasis and pityriasis rubra pilaris with CARD 14 mutations. We report a 5-month-old female infant who developed CAPE-associated erythroderma. Although she did not respond to conventional therapies, she responded well to ustekinumab treatment at the age of 4 years.
Assuntos
Dermatite Esfoliativa , Exantema , Pitiríase Rubra Pilar , Psoríase , Pré-Escolar , Feminino , Humanos , Lactente , Proteínas Adaptadoras de Sinalização CARD/genética , Dermatite Esfoliativa/diagnóstico , Dermatite Esfoliativa/tratamento farmacológico , Exantema/tratamento farmacológico , Guanilato Ciclase/genética , Guanilato Ciclase/uso terapêutico , Proteínas de Membrana/uso terapêutico , Pitiríase Rubra Pilar/diagnóstico , Pitiríase Rubra Pilar/tratamento farmacológico , Psoríase/diagnóstico , Psoríase/tratamento farmacológico , Psoríase/genética , Ustekinumab/uso terapêuticoRESUMO
COVID-19 caused by the SARS-CoV-2, became pandemic very quickly. Management of severe dermatologic disorders in patients who require systemic immunosuppressive treatment is a major concern in COVID-19 pandemic era. Here, we report a 45-year-old homeless addicted male with second flare of psoriatic erythroderma and positive PCR test for COVID 19. His first attack occurred two months earlier, when he was screened for SARS-CoV-2 before admission which all evaluations showed nagative results. The patient was treated and relatively controlled with cyclosporine and therefore he was discharged. During this interval, he not only discontinued his medication, but also became SARS-CoV-2 positive. It seems that both factors participated in flare of his erythroderma.
Assuntos
COVID-19 , Dermatite Esfoliativa , COVID-19/complicações , Ciclosporina/uso terapêutico , Dermatite Esfoliativa/tratamento farmacológico , Dermatite Esfoliativa/etiologia , Humanos , Masculino , Pessoa de Meia-Idade , Pandemias , SARS-CoV-2RESUMO
The current case report presents a case of non-thymoma-associated exfoliative dermatitis in an 8-year-old European Shorthair female cat. The animal displayed extensive alopecia and excessive peeling of the epidermis. There were no other apparent disorders, except for the skin lesions. Roentgenographic and sonographic examinations, complete blood count and blood serum chemistry analyses, and skin biopsy were performed. The histopathological investigation revealed hyperkeratosis of the epidermis and the infiltration of lymphocytes and macrophages at the dermal-epidermal junction around the hair follicles and sebaceous glands. Moreover, edema of the basal layer and melanin migration from the epidermis to the dermis were observed. The patient underwent treatment with immunosuppressive doses of prednisolone, antibiotic therapy, and baths in anti-seborrheic shampoos and displayed resolution. However, recurrence was observed after one month. Consequently, the patient received cyclosporine A, in addition to the aforementioned treatment and the lesions resolved without relapse.
Assuntos
Doenças do Gato , Dermatite Esfoliativa , Animais , Gatos , Ciclosporina , Dermatite Esfoliativa/diagnóstico , Dermatite Esfoliativa/tratamento farmacológico , Dermatite Esfoliativa/etiologia , Dermatite Esfoliativa/veterinária , Epiderme/patologia , Feminino , Imunossupressores , RecidivaRESUMO
With the onset of the COVID-19 pandemic, healthcare providers have made increasing use of inpatient teledermatology; however, few studies have analysed the impact of teledermatology on patient outcomes. In this study, we investigated the diagnostic concordance between the primary team and teledermatologist, and we analysed the impact of this technology on the diagnosis and management of erythroderma, a condition with high morbidity and mortality. Overall, out of 2987 inpatient teledermatology encounters reviewed, we found 33 cases of erythroderma, and, of these, 78.8% had a change in diagnosis after teledermatology consult, 81.8% were recommended biopsy and all patients had a change in topical/systemic therapy. We hope to promote further study of the efficacy of teledermatology as it may begin to address large gaps in dermatological access to care particularly in regional and community hospitals.
Assuntos
Dermatite Esfoliativa/diagnóstico , Hospitalização , Telemedicina , Idoso , COVID-19/epidemiologia , Dermatite Esfoliativa/tratamento farmacológico , Diagnóstico Diferencial , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Avaliação de Resultados em Cuidados de Saúde , Pandemias , Estudos RetrospectivosAssuntos
Abatacepte/administração & dosagem , Abatacepte/efeitos adversos , Artrite Psoriásica/tratamento farmacológico , Dermatite Esfoliativa/induzido quimicamente , Dermatite Esfoliativa/tratamento farmacológico , Exacerbação dos Sintomas , Antirreumáticos/administração & dosagem , Humanos , Masculino , Pessoa de Meia-IdadeRESUMO
Exfoliative dermatitis (ED) or erythroderma is defined as diffuse erythema and scaling of the skin involving more than 90% of the total body skin surface, which can be caused by variety of systemic and cutaneous diseases, such as infection, including dermatophytosis. Dermatophytosis is a superficial fungal infection of keratinized tissue caused by dermatophytes. There are only few case reports of ED due to dermatophytosis in literature. A 39-year-old male present with history of diffuse erythematous macules and scales almost on entire body due to dermatophytosis was reported. The diagnosis of dermatophytosis was confirmed by direct microscopic examination, fungal culture, and histopathological examination. Patient was treated with 2% ketoconazole shampoo and two pulses of 1-week of 200 mg itraconazole twice a day for each month. Clinical improvement was showed on the 7th day of observation characterized by decreasing of erythematous macules and scales. Mycological and clinical improvements were obtained on the 29th day of observation. The etiology of ED should be determined in order to give an appropiate treatment.
Assuntos
Dermatite Esfoliativa/diagnóstico , Dermatite Esfoliativa/microbiologia , Dermatomicoses/diagnóstico , Pele/microbiologia , Adulto , Antifúngicos/farmacologia , Dermatite Esfoliativa/tratamento farmacológico , Dermatomicoses/tratamento farmacológico , Técnicas Histológicas , Humanos , Masculino , Pele/efeitos dos fármacos , Pele/patologiaAssuntos
Antirreumáticos , Artrite Psoriásica , Dermatite Esfoliativa , Infecções por HIV , Antirreumáticos/uso terapêutico , Artrite Psoriásica/tratamento farmacológico , Dermatite Esfoliativa/diagnóstico , Dermatite Esfoliativa/tratamento farmacológico , Etanercepte/uso terapêutico , Infecções por HIV/complicações , Infecções por HIV/diagnóstico , Infecções por HIV/tratamento farmacológico , Humanos , Indução de Remissão , Resultado do TratamentoRESUMO
BACKGROUND: To date, very few studies on clinical-histopathological correlations of cutaneous disorders associated with COVID-19 have been conducted. CASE PRESENTATION: The Case 1 was a 90-year-old man, who tested positive for SARS-CoV-2 from a nasopharyngeal swab. Two days later, he was hospitalized and after eleven days transferred to Intensive Care Unit. A chest CT showed bilateral ground-glass opacities. Just that day, an erythematous maculo-papular rash appeared on trunk, shoulders and neck, becoming purpuric after few days. Histological evaluations revealed a chronic superficial dermatitis with purpuric aspects. The superficial and papillary dermis appeared edematous, with a perivascular lympho-granulocytic infiltrate and erythrocytic extravasation. At intraepithelial level, spongiosis and a granulocyte infiltrate were detected. Arterioles, capillaries and post-capillary venules showed endothelial swelling and appeared ectatic. The patient was treated with hydroxychloroquine, azithromycin, lopinavir-ritonavir and tocilizumab. Regrettably, due to severe lung impairment, he died. The Case 2 was a 85-year-old man, admitted to Intensive Care Unit, where he was intubated. He had tested positive for SARS-CoV-2 from a nasopharyngeal swab two days before. A chest RX showed bilateral atypical pneumonia. After seven days, a cutaneous reddening involving trunk, upper limbs, neck and face developed, configuring a sub-erythroderma. Histological evaluations displayed edema in the papillary and superficial reticular dermis, and a perivascular lymphocytic infiltrate in the superficial dermis. The patient was treated with hydroxychloroquine, azithromycin, lopinavir-ritonavir and tocilizumab. Sub-erythroderma as well as respiratory symptoms gradually improved until healing. CONCLUSIONS: The endothelial swelling detected in the Case 1 could be a morphological expression of SARS-CoV-2-induced endothelial dysfunction. We hypothesize that cutaneous damage could be initiated by endothelial dysfunction, caused by SARS-CoV-2 infection of endothelial cells or induced by immune system activation. The disruption of endothelial integrity could enhance microvascular permeability, extravasation of inflammatory cells and cytokines, with cutaneous injury. The Case 2 developed a sub-erythroderma associated with COVID-19, and a non-specific chronic dermatitis was detected at histological level. We speculate that a purpuric rash could represent the cutaneous sign of a more severe coagulopathy, as highlighted histologically by vascular abnormalities, while a sub-erythroderma could be expression of viral hematogenous spreading, inducing a non-specific chronic dermatitis.